Partners
Cooperating partners
ResearchGate
Cooperating conferences
EACR-Boehringer Ingelheim Conference: Drugging and Regulating the MAP Kinase Pathway
Time and Venue: 11-12 February 2025| Virtual meeting, worldwide access
About: Organized by the European Association for Cancer Research (EACR) with
Boehringer Ingelheim. We return to this topic for its second edition to focus on the basic and clinical aspects of the regulation of the Mitogen Activated Protein Kinase (MAPK) pathway, one of the most commonly mutated signalling pathways in human cancers. The programme will include new insights about the mechanisms of action of the new generation of pan-RAS inhibitors and rational combination therapies. Whether you work in academia or industry, if you’re interested in the role of the MAPK pathway in the context of genetically targeted and immune-based anticancer therapies then this is not a meeting you should miss! It will also focus on the mechanistic aspects of gene regulation, target validation, and drug development, as well as emerging translational and clinical opportunities of small molecule inhibitors.
8th World Congress on Controversies in Breast Cancer (CoBrCa) in partnership with the UK Association of Breast Surgery (ABS)
Time and Venue: September 11-13, 2024| Edinburgh, Scotland, UK
About:
The 8th World Congress on Controversies in Breast Cancer (CoBrCa), held in partnership with the UK Association of Breast Surgery (ABS), will take place at the Edinburgh International Conference Centre (EICC) in Edinburgh, Scotland, UK from September 11-13, 2024.
The 8th CoBrCa Congress will continue to directly address key and controversial issues facing clinicians in their daily practice in an effort to find solutions to unresolved clinical and therapeutic problems. Experts, from different disciplines, from all over the world will debate, discuss, and present lectures on topics in medical oncology, surgery, breast imaging, radiation oncology, pathology, reconstruction, and more. At the end of each lecture, participants will be provided with ample time to join the discussion. The program is aimed at medical oncologists, surgeons, radiologists, radiation oncologists, pathologists, nurses, students, residents, and allied health professionals. Register before the early deadline of June 11, 2024 in order to save: https://cobrca.org/register-for-the-cobrca-experience/
Don’t forget to submit an abstract for oral or poster presentation and share your knowledge: https://cobrca.org/call-for-abstracts/
Website: https://cobrca.org/
2nd International Summit on Toxicology and Applied Pharmacology
Time and Venue: May 27-29, 2024 | Prague, Czech Republic
About:
Spectrum Conferences delightedly welcomes you to the 2nd International Summit on Toxicology and Applied Pharmacology, which is going to be held from May 27-29, 2024, in Prague, Czech Republic
The meeting brings together World-Class participants and young researchers looking for opportunities for exchanges that cross the traditional discipline boundaries and allow them to solve multidisciplinary challenging problems that only a venue of this nature can offer. Through this event, you will be able to share state-of-the-art developments and cutting-edge technologies in the broad areas of Toxicology and Applied Pharmacology. We sincerely hope that ISTAP2023 serves as an international platform for meeting researchers from around the world, widening professional contact, and creating new opportunities, including establishing new collaborations.
We are looking forward to seeing you at ISTAP2024 in Prague, Czech Republic.
Breast and Women's Cancer
Time and Venue: July 12-13, 2023 | Paris, France.
About: Scholars Global Summit on Breast and Women's Cancer balances clinical, translational, and basic research, including Keynote speeches and Invited speeches given by forum for interaction, communication, and education for a broad spectrum of researchers, health professionals, and those with a special interest in Cancer related to women’s health, i.e., from the most common Women's cancer - Breast, Colorectal, Cervical, Ovarian, Uterine, Vaginal, Vulvar to the rarest fallopian tube cancer.
ISTAP2023 International Summit on Toxicology and Applied Pharmacology
Time and Venue: April 27-29, 2023 | Valencia, Spain
About: Spectrum Conferences delightedly welcomes you to the International Summit on Toxicology and Applied Pharmacology which is going to be held from April 27-29, 2023 in Valencia, Spain.
The meeting brings together World Class participants and young researchers looking for opportunities for exchanges that cross the traditional discipline boundaries and allow them to solve multidisciplinary challenging problems that only a venue of this nature can offer.
Through this event, you will be able to share state-of-the-art developments and cutting-edge technologies in the broad areas of Toxicology and Applied Pharmacology.
We sincerely hope that ISTAP2023 serves as an international platform for meeting researchers from around the world, widening professional contact, and creating new opportunities, including establishing new collaborations.
We are looking forward to seeing you at ISTAP2023 in Valencia, Spain.
The meeting brings together World Class participants and young researchers looking for opportunities for exchanges that cross the traditional discipline boundaries and allow them to solve multidisciplinary challenging problems that only a venue of this nature can offer.
Through this event, you will be able to share state-of-the-art developments and cutting-edge technologies in the broad areas of Toxicology and Applied Pharmacology.
We sincerely hope that ISTAP2023 serves as an international platform for meeting researchers from around the world, widening professional contact, and creating new opportunities, including establishing new collaborations.
We are looking forward to seeing you at ISTAP2023 in Valencia, Spain.
Cancer Immunotherapy and Immunomonitoring (CITIM-2023)
Time and Venue: April 24 - 27, 2023 | Vilnius, Lithuania
About: The main goal of this meeting is to provide a joint forum for leading basic researchers and clinical investigators in the fields of cancer immunology and immunotherapy that would serve to accelerate translation of basic research into effective treatment of cancer in children and adults.
Session highlights will include:
Inflammation, Regulatory Cells, Cancer, Metastases
Immune Tolerance and Immune Escape in Cancer
Targeting the Tumor Microenvironment: New Approaches
New Vaccines, Antibodies and Immunomodulators
Cellular, Molecular and Genetic Immunotherapy for Cancer
Combinatorial Approaches for Cancer Therapy
Biomarkers and Immunoscores in Cancer
Immunodiagnostics and Immunomonitoring
Session highlights will include:
Inflammation, Regulatory Cells, Cancer, Metastases
Immune Tolerance and Immune Escape in Cancer
Targeting the Tumor Microenvironment: New Approaches
New Vaccines, Antibodies and Immunomodulators
Cellular, Molecular and Genetic Immunotherapy for Cancer
Combinatorial Approaches for Cancer Therapy
Biomarkers and Immunoscores in Cancer
Immunodiagnostics and Immunomonitoring
Website: https://www.canceritim.org/
Previous conferences
43rd EORTC-PAMM
Time and Venue: December 15-17 2022 | Florence, Italy
About: The 43rd Meeting of the European Organization of Research and Treatment of Cancer (EORTC) – Pharmacology and Molecular Mechanisms (PAMM) Group will be held on December 15-17, 2022 in Florence, Italy. This year, the main topics will be innovation and application of pharmacological knowledge to cancer drug discovery and development, with particular regard to innovative and advanced drugs and their mechanisms of action, pharmacometrics, and clinical application in oncology.
As usual, we count on having a good number of participants (cancer pharmacologists, clinical oncologists, and cancer scientists), offering a high-level scientific program, and counting on the participation of National and International key opinion leaders as speakers and chairmen. The estimated attendees are about 150 in person and 250 in remotely.
As usual, we count on having a good number of participants (cancer pharmacologists, clinical oncologists, and cancer scientists), offering a high-level scientific program, and counting on the participation of National and International key opinion leaders as speakers and chairmen. The estimated attendees are about 150 in person and 250 in remotely.
Website: https://www.pamm-meeting.com/
Leipzig Immune ONcology (LION) Conference
Time and Venue: 22-23 November 2022 | Virtual Conference
About: The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss the latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Cancer Center of the University Hospital Leipzig. We are looking forward to welcoming you virtually on 22-23 November 2022 at LION 2022.
Website: https://www.lion-conference.com/
Australasian International Breast Congress (AIBC)
Time and Venue: October 13-15, 2022. | Brisbane, Australia
About: We are pleased to announce that the Australasian International Breast Congress will be held jointly with the Australasian Society for Breast Disease (ASBD), 6th World Congress on Controversies in Breast Cancer (CoBrCa) and Breast Surgeons of Australia and New Zealand (BreastSurgANZ). This most important congress will take place at the Brisbane Convention and Exhibition Centre (BCEC) in Brisbane, Australia October 13-15, 2022.
The Joint Congress will address key issues facing clinicians in their daily practice, including medical oncology, surgery, radiation oncology, breast imaging, pathology, reconstruction, allied health and survivorship issues. Through a format of debates, lectures and panel discussions, the congress will provide a forum to effectively address unresolved clinical and therapeutic problems. There will also be workshops which will address educational needs of the audience.
The Joint Congress will address key issues facing clinicians in their daily practice, including medical oncology, surgery, radiation oncology, breast imaging, pathology, reconstruction, allied health and survivorship issues. Through a format of debates, lectures and panel discussions, the congress will provide a forum to effectively address unresolved clinical and therapeutic problems. There will also be workshops which will address educational needs of the audience.
Register before the early deadline of July 13 in order to save: https://aib-congress.org/register-for-the-aib-congress/
Don’t forget to submit an abstract and share your knowledge: https://aib-congress.org/call-for-abstracts/
Website: https://aib-congress.org/
Biomarkers UK: In-Person
Time and Venue: 03-04 May 2022 | London, UK
About: Europe's foremost Biomarkers Congress returns for the 17th year on the 3rd and 4th of May 2022 in London, UK, with a dedicated Digital Day on the 5th. Featuring over 90 expert-led presentations and eight interactive tracks on the latest innovations, this event is an unmissable opportunity to learn the trends and technologies in biomarkers for drug discovery, diagnostics, clinical development, and beyond.
Leipzig Immune ONcology (LION) Conference
Time and Venue: 9-10 November 2021 | Virtual Conference
About: The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Cancer Center of the University Hospital Leipzig. It will be held under the auspices of the German Society of Hematology and Medical Oncology (DGHO).
We are looking forward to welcoming you virtually on 9-10 November 2021 at LION 2021.
We are looking forward to welcoming you virtually on 9-10 November 2021 at LION 2021.
Website: https://www.lion-conference.com/
8th Immunotherapy of Cancer Conference (ITOC8)
Time and Venue: 8-9 October 2021 | Virtual Conference
About: The 8th Immunotherapy of Cancer Conference (ITOC8) is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.
ITOC8 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery
ITOC8 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery
Website: https://www.itoc-conference.eu/
The SOHO (Society of Hematologic Oncology) 3rd Italian Conference
Time and Venue: 27-30 September 2021 | Rome-Italy
About: The SOHO (Society of Hematologic Oncology) 3rd Italian Conference, is bringing together leading SOHO experts and top Italian researchers in leukemias, lymphomas, multiple myeloma, MPNs, MDSs, and rare diseases, with the aim to consolidate the Italian Hematology-SOHO partnership.
It will cover the latest advances in the pathophysiology and therapy of hematological malignancies such as: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non Hodgkin and Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, Myelofibrosis.
It also serves to spread the importance to the Italian Scientific Community about the new scientific society "ITALIAN SOCIETY OF HEMATOLOGIC ONCOLOGY" (SOHO ITALY).
The aim of the association is the integration of the clinical-scientific activities of IRST Meldola and MD ANDERSON CANCER CENTER and the improvement of the clinical-therapeutic approach to patients with hematologic malignancies.
The Society "SOHO ITALY" is represented by G. Martinelli and C. Cerchione (IRST MELDOLA) and H. Kantarjian, E. Jabbour, M. Konopleva, N. Daver.
The Italian Society of Hematologic Oncology (SOHO Italy) was established as a non-profit organization in 2019 to promote worldwide research (education, prevention, clinical studies and patient care) into hematologic malignancies and related disorders. The Italian SOHO network, related to American SOHO network, aims to compare Italian and American management of hematologic malignancies, and to share most innovative updates in this field.
It will cover the latest advances in the pathophysiology and therapy of hematological malignancies such as: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non Hodgkin and Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, Myelofibrosis.
It also serves to spread the importance to the Italian Scientific Community about the new scientific society "ITALIAN SOCIETY OF HEMATOLOGIC ONCOLOGY" (SOHO ITALY).
The aim of the association is the integration of the clinical-scientific activities of IRST Meldola and MD ANDERSON CANCER CENTER and the improvement of the clinical-therapeutic approach to patients with hematologic malignancies.
The Society "SOHO ITALY" is represented by G. Martinelli and C. Cerchione (IRST MELDOLA) and H. Kantarjian, E. Jabbour, M. Konopleva, N. Daver.
The Italian Society of Hematologic Oncology (SOHO Italy) was established as a non-profit organization in 2019 to promote worldwide research (education, prevention, clinical studies and patient care) into hematologic malignancies and related disorders. The Italian SOHO network, related to American SOHO network, aims to compare Italian and American management of hematologic malignancies, and to share most innovative updates in this field.
Immuno Week: Online
Time and Venue: 6-9 July 2021 | BST (UTC+1)
About: Oxford Global is proud to present Immuno Week: Online, taking place 6 – 9 July 2021. Across the week, expert speakers will provide you with a forward-looking perspective on the opportunities and challenges impacting market growth in immuno-oncology from discovery through to the clinic.
The four-day congress offers an interactive online platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions. It will bring together over 800 senior industry experts and key opinion leaders in immuno-oncology.
Website: https://oxfordglobal.com/immuno/
EORTC-PAMM Meeting
Time and Venue: 21-22 April 2021 | Virtual Event
About: EORTC is an independent, non-profit cancer research organization, our mission is to coordinate and conduct international translational and clinical research to improve the standard of cancer treatment for patients. The aim ultimately to increase people’s survival and quality of life by testing new therapeutic strategies based on existing drugs, surgery and radiotherapy. We also help develop new drugs and approaches in partnership with the pharmaceutical industry and in patients’ best interests.
The EORTC-PAMM groups appreciates the kind willingness of the journal Cancer Drug Resistance to sponsor two awards for the best presentation on each day of the meeting.
The EORTC-PAMM groups appreciates the kind willingness of the journal Cancer Drug Resistance to sponsor two awards for the best presentation on each day of the meeting.
7th Immunotherapy of Cancer Conference (ITOC7)
Time and Venue: 2-3 October 2020 | Virtual Conference
About: The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich, Germany from October 2-3, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation to address its unique challenges.
ITOC7 is organized by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
ITOC7 is organized by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
Website: https://www.itoc-conference.eu/
9th Immunotherapy of Cancer Conference (ITOC9)
Time and Venue: September 22-24, 2022 | Munich, Germany
About: The 9th Immunotherapy of Cancer Conference (ITOC9) to be held in Munich, Germany from September 22-24, 2022 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation to address its unique challenges.
ITOC9 is organized by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
ITOC9 is organized by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
Website: https://www.itoc-conference.eu/
Extracellular matrix pharmacology congress (ECM2022)
Time and Venue: 23-25 June 2022 | Copenhagen, Denmark.
About: The aim of the congress is to discover new drugs and bring together extracellular matrix experts across disease fields. Alterations to the extracellular matrix are a common denominator in most chronic diseases. It is time to create a forum for experts to discuss, share and learn from other disease fields!
Session highlights will include:
The essential components of the ECM
The importance of ECM in cancer: Barrier for entry or exit?
Should we treat the ECM or cells in fibrotic diseases?
The importance of ECM in lung diseases
The importance of ECM in liver diseases
Cardiorenal axis and the ECM
Tissue destruction in inflammatory diseases
Pharmacological targets of the ECM
ECM signaling
Session highlights will include:
The essential components of the ECM
The importance of ECM in cancer: Barrier for entry or exit?
Should we treat the ECM or cells in fibrotic diseases?
The importance of ECM in lung diseases
The importance of ECM in liver diseases
Cardiorenal axis and the ECM
Tissue destruction in inflammatory diseases
Pharmacological targets of the ECM
ECM signaling
Website: https://ecm-congress.org/
